Molecular simulation reveals how the host thromboinflammatory C-type lectin receptor CLEC2 interacts with the receptor-binding domain of SARS-CoV-2
The outcomes of this study highlight the molecular basis of CLEC2-mediated thromboinflammation in COVID-19, which is driven by the release of extracellular vesicles, and provide a framework for developing targeted therapeutics to mitigate the risk of post-acute Covid-19 sequelae.